Computational simulations for structural heart devices
Scope of the method
- Human health
- Regulatory use - Routine production
- Translational - Applied Research
- Animal derived cells / tissues / organs
- Streamlining and accelerating R&D
- Structural heart interventions
In the early phases of the design cycle of structural heart devices, choosing which prototype to develop can be complicated. There are a lot of unknowns to contend with. FEops’ simulation technology helps fill in these blanks. It gives product developers computational simulations that let them evaluate the performance of multiple prototypes in terms of radial strength, crimpability, fatigue safety, deployment behavior in validated virtual human and animal patients, provided by the customer or selected from the large FEops proprietary database including both pathological and healthy patients. FEops has developed unique, proprietary simulation technology that uses multi-phase, preoperative CT data to predict and investigate realistic loading conditions of any cardiac device. This enables experimental chambers to be designed for fatigue and durability tests able to clone the in vivo cyclic load experienced by the device implanted in the actual patients.
Computer computational infrastructure
- Published in peer reviewed journal
Pros, cons & Future potential
This is method is faster, cheaper and reduces the number of animal testing.
References, associated documents and other information